MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 206 participants.

Also called NCT03545607

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 206 participants (enrolled count) (from the registry)
Sponsor
  • Healios K.K. Registry lists this organization as the lead sponsor
  • Medpace, Inc. Registry lists this organization as a collaborator
Registry
  • NCT NCT03545607
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Taiwan (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT03545607. Randomized; quadruple masking; primary purpose treatment. Start 2018-07-28 (actual); primary completion 2024-10-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study
Acronym
MASTERS-2
Intervention (Biological)
MultiStem
Intervention (Biological)
Placebo
Lead sponsor
Healios K.K. (class: industry)
Collaborator
Medpace, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03545607
Content hash
9e1031f5a0e2f655a7fadd903323a68f3f6eebcca54125b7243dbde192fa169c